| ICAD(n = 84) | VAD(n = 56) | OR(95%CI) | P value |
---|---|---|---|---|
Intravenous thrombolysis | 4 (4.76%) | 2 (3.57%) | 1.35 (0.31-7.28) | 0.733 |
Anticoagulation | 4 (4.76%) | 0 (0%) | 6.32 (0.33-119.8) | 0.098 |
Anti-platelet | 80 (95.24%) | 56 (100%) | 0.16 (0.01-3.00) | 0.098 |
Endovascular procedures | 10 (11.90%) | 4 (7.14%) | 1.96 (0.64-5.83) | 0.358 |
Initial NIHSS | 6.54 ± 5.93 | 4.66 ± 5.67 | 0.94 (0.89-1.00) | 0.041 |
NIHSS at discharge | 3.85 ± 4.06 | 3.45 ± 4.82 | 0.98 (0.90-1.06) | 0.598 |
Initial MRS (≤2) | 55 (65.48%) | 47 (83.93%) | 0.36 (0.15-0.83) | 0.016 |
MRS(≤2) at discharge | 69 (82.14%) | 50 (89.29%) | 0.55 (0.20-1.44) | 0.246 |